questions for p.c, page-10

Lakey,

State to Peter Cook, he told shareholders in 2008 he had normalised relationship with GSK and told shareholders Andrew Witty was enthusiasistic about Relenza and he Peter Cook told shareholders not to be alarmed for Relenza not to be reported in the news. Despite Peter Cook receiving free oopies, and the problems with Tamiflu, Relenza continues to trail Tamiflu year after year at less than 10% of the flu antiviral market.

Ask PC how he is going to get GSK to carry out their contractual obligations to market Relenza with best efforts.